GHRP-6

Hexapeptide GH secretagogue with appetite-stimulating profile.

Half-life~30 minutes plasma
Dose range100 to 300 mcg per administration, 1 to 3 times daily · 8 to 12 week cycle
Reconstituted stability28 days, 2–8 °C
VerificationCOA included

Mechanism

How it works.

GHSR-1a receptor agonist. Stimulates GH release; meaningful appetite-stimulating effect via ghrelin pathway activation.

Research

What the research shows.

Research base on GH release is well-characterised. Appetite-stimulating profile differentiates from GHRP-2 and Ipamorelin.

GHRP-6 is a synthetic hexapeptide that stimulates GH release via the ghrelin receptor. The defining feature compared with GHRP-2 and Ipamorelin is meaningful appetite stimulation, which can be useful or unwanted depending on the protocol goal.

Research-context use leans toward bulking-research protocols where the appetite increase is favourable. For composition-research protocols, GHRP-2 or Ipamorelin are usually preferred.

Contraindications

When not to use.

Active malignancy. Disordered eating. Pregnancy. Pediatric use without clinical oversight.

Tool Calculate dose → Reconstitution math + syringe units Tool Build a stack → Get a curated protocol with this compound Shop Buy GHRP-6 → COA included · cold-chain dispatched

Information is educational, derived from published research. Not medical advice. All compounds sold for research use only. Bloodwork and a clinical consultation should precede any new protocol.